Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,101–4,125 of 7,816 matching trials · page 165 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults NCT05804279 BPDO-1603 Runs in: South Korea · 1 site |
PHASE1 other |
COMPLETED | 24 | Hyundai Pharm INDUSTRY |
2023-04-07 |
|
A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants NCT05686980 ABBV-552 Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 18 | AbbVie INDUSTRY |
2023-04-06 |
|
PIPAF Platelets in the Pathogenesis of Ageing Associated Frailty NCT05798637 Standard of care Runs in: Italy · 2 sites |
NA other |
UNKNOWN | 200 | Azienda Ospedaliera di Perugia OTHER |
2023-04-06 |
|
Examining the Relationship Between Hormone Therapy (HT) and Cognitive Function (The WHIMS-ECHO Study) NCT00745056 Runs in: United States · 1 site |
NA other |
COMPLETED | 2,922 | Wake Forest University Health Sciences OTHER |
2023-04-04 |
|
IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression NCT02801877 IntelliCare; Hub App with the Recommender System; Coaching Runs in: United States · 1 site |
NA other |
COMPLETED | 301 | Northwestern University OTHER |
2023-04-04 |
|
Feasibility Study of "My Tools 4 Care-In Care" for Family Caregivers of Residential-Living Older Persons With Dementia NCT03571165 My Tools 4 Care - In Care Runs in: Canada · 1 site |
NA other |
COMPLETED | 37 | University of Alberta OTHER |
2023-04-04 |
|
Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects NCT05503511 NPT 2042 (bumetanide analog) or Matching Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 50 | NeuroPro Therapeutics, Inc. INDUSTRY |
2023-04-04 |
|
Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning? NCT04276610 Low Vision Reading Rehabilitation Runs in: Canada · 2 sites |
NA other |
TERMINATED | 38 | Université de Montréal OTHER |
2023-04-03 |
|
Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging NCT03846232 No intervention Runs in: Spain · 1 site |
NA other |
COMPLETED | 60 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation OTHER |
2023-03-31 |
|
BarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors Disclosure NCT03847038 Preventive strategies advice and dementia risk estimate disclosure Runs in: Spain · 1 site |
NA other |
COMPLETED | 306 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation OTHER |
2023-03-31 |
|
Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease NCT05267028 AD-TAR; AD-Cognitive Stimulation Runs in: Monaco · 1 site |
NA other |
COMPLETED | 16 | Association de Recherche Bibliographique pour les Neurosciences OTHER |
2023-03-31 |
|
Establishment of a CSF Bank for the Development of Biomarkers of Smooth Muscle Cell (SMC) Damage in Monogenic Cerebral Small Vessel Disease NCT05793424 Cerebrospinal fluid (CSF) sample and additional blood samples |
NA other |
UNKNOWN | 90 | Assistance Publique - Hôpitaux de Paris OTHER |
2023-03-31 |
|
Hear Me Read 2021 Clinical Trial NCT05245799 Speech Language Therapy; Digital Software Application Runs in: United States · 1 site |
NA other |
UNKNOWN | 50 | Prasanth Pattisapu OTHER |
2023-03-30 |
|
Feasibility of a Method for Analysis of Alzheimer´s Disease Specific Proteins in Nasal Secretion NCT05791552 Collection of nasal secretion Runs in: Germany · 1 site |
NA other |
UNKNOWN | 500 | Noselab GmbH INDUSTRY |
2023-03-30 |
|
Care EcoSystem: Ochsner Health System NCT03916718 Care EcoSystem Runs in: United States · 1 site |
NA other |
COMPLETED | 290 | Ochsner Health System OTHER |
2023-03-29 |
|
Spaced Retrieval as Treatment for Aphasia NCT04623125 Spaced Retrieval Practice Runs in: Canada · 1 site |
NA other |
COMPLETED | 21 | Rotman Research Institute at Baycrest OTHER |
2023-03-29 |
|
Possible Therapy by Phone for Caregivers NCT04634396 ACT Acceptance and Commitment Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Indiana University OTHER |
2023-03-29 |
|
Retinal Metabolic Imaging of Alzheimer Patient NCT03420807 MHRC Runs in: Canada · 1 site |
NA other |
COMPLETED | 49 | Optina Diagnostics Inc. INDUSTRY |
2023-03-28 |
|
The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training. NCT05788133 treatment and screening by neuropsychological tests on humanoid robot Runs in: Italy · 1 site |
NA other |
COMPLETED | 65 | IRCCS Centro Neurolesi Bonino Pulejo OTHER |
2023-03-28 |
|
The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias NCT04250376 Focused Transcranial Ultrasound Runs in: United States · 1 site |
NA other |
UNKNOWN | 100 | Neurological Associates of West Los Angeles OTHER |
2023-03-24 |
|
Eye to Brain Connection NCT05215782 Runs in: United States · 1 site |
NA other |
COMPLETED | 65 | Optina Diagnostics Inc. INDUSTRY |
2023-03-24 |
|
Brief Telehealth Cognitive Rehabilitation Following Mild TBI NCT05315453 Brief Cognitive Rehabilitation Runs in: United States · 1 site |
NA other |
COMPLETED | 28 | University of Washington OTHER |
2023-03-24 |
|
The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia NCT05633095 Neuclare Runs in: South Korea · 2 sites |
NA other |
UNKNOWN | 20 | Deepsonbio INDUSTRY |
2023-03-24 |
|
Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856 NCT05783830 ACD856 Runs in: Sweden · 1 site |
EARLY_PHASE1 other |
COMPLETED | 6 | AlzeCure Pharma INDUSTRY |
2023-03-24 |
|
Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy NCT02861846 profile of CSF biomarkers of AD Runs in: France · 4 sites |
NA other |
COMPLETED | 35 | Hospices Civils de Lyon OTHER |
2023-03-23 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial